ANIK
ANIK
US0352551081
Anika Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
262.04M EUR
194.66M EUR
193.68M EUR
133.47M EUR
Enterprise Value
244.19M EUR
181.5M EUR
178.39M EUR
102.24M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
20.61x
--
--
--
Price to Sales
2.17x
1.61x
1.67x
1.54x
Price to Book
1.91x
1.42x
1.45x
0.93x
EV/Revenue
2.02x
1.5x
1.53x
1.18x
EV/EBITDA
80.33x
354.49x
--
--
Price to FCF (P/FCF)
85.57x
346.37x
186.41x
18.24x
EV/FCF
79.74x
322.95x
171.7x
13.97x
FCF Yield
1.17%
0.29%
0.54%
5.48%
ende